Foye's Principles of Medicinal ChemistryDavid A. Williams, William O. Foye, Thomas L. Lemke Lippincott Williams & Wilkins, 2002 - 1114 sivua This comprehensive Fifth Edition has been fully revised and updated to meet the changing curricula of medicinal chemistry courses. The new emphasis is on pharmaceutical care that focuses on the patient, and on the pharmacist a therapeutic clinical consultant, rather than chemist. Approximately 45 contributors, respected in the field of pharmacy education, augment this exhaustive reference. New to this edition are chapters with standardized formats and features, such as Case Studies, Therapeutic Actions, Drug Interactions, and more. Over 700 illustrations supplement this must-have resource. |
Sisältö
Introduction Origins of Medicinal Chemistry | 1 |
Drugs Affecting Central | 86 |
A Perspective | 518 |
Drugs Affecting Cholinergic | 541 |
Antithrombotics Thrombolytics Coagulants | 604 |
Drugs Affecting the Hormonal Systems | 629 |
ROBERT GRIFFITH | 891 |
653 | 924 |
JAMES T DALTON | 952 |
Thyroid Function and Thyroid Drugs | 982 |
Drugs Affecting the Immune Systems | 1052 |
Nonsteroidal AntiInflammatory Agents | 1059 |
Antihistamines and Related Antiallergic | 1070 |
Muita painoksia - Näytä kaikki
Foye's Principles of Medicinal Chemistry David A. Williams,William O. Foye,Thomas L. Lemke Esikatselu ei käytettävissä - 2002 |
Yleiset termit ja lausekkeet
5-HT receptors absorption acetylcholine activity administration adrenergic affinity agents agonists amine amino acid analgesic analogs anesthetic angiotensin antagonists aromatic atoms barbiturates benzodiazepines binding bioavailability biological blockers blood bond brain calcium carbon carboxylic cardiac cell ceptors CH3 CH3 channel Chem chemical chemistry clinical clonidine compounds conjugation COOH decrease derivatives diazepam diltiazem disease diuretics dopamine dosage dose drug elimination enantiomers enzyme ester excreted functional groups GABA glucuronide glycosides half-life hepatic hormone human hydrolysis hydroxylation hypertension increase inhibition inhibitors interactions isoforms ligand lipophilic liver mechanism of action membrane metabolism metabolites methyl molecular molecule morphine muscarinic muscle neurons norepinephrine OCH3 opioid oral oxidation pathway patients peptide pharmacokinetic Pharmacol pharmacologic phenobarbital phenytoin plasma concentration potential properties protein renal result ring seizures selective serotonin side effects sodium solubility stimulation structure structure-activity studies substrate synthesis therapeutic therapy tion tissue toxicity treatment urine Verapamil xenobiotics